Literature DB >> 22611114

Aggressive posterior retinopathy of prematurity in large preterm babies in South India.

Parag K Shah1, Venkatapathy Narendran, Narendran Kalpana.   

Abstract

OBJECTIVE: To describe aggressive posterior retinopathy of prematurity (APROP) in a subset of premature babies, having gestational age (GA) of ≥28 weeks and birth weight (BW) of ≥1000 g.
DESIGN: Retrospective observational case series. SETTING AND PATIENTS: Case records of 99 babies, who were diagnosed to have APROP between July 2002 and October 2010 were reviewed. Fundus fluorescein angiography (FFA) was carried out in 19 babies.
RESULTS: The mean GA was 31.7 weeks (range 28-35 weeks) and mean BW was 1572 g (range 1000-2310 g). All these babies received supplemental unblended oxygen 3 days or longer after birth. Of the 52 babies who had an eye exam in the neonatal intensive care unit prior to discharge, 35 babies had loss of vascularised retina from zone II to zone I and four babies from zone III to zone I, when examined as an outpatient. FFA revealed large geographic areas of vaso-obliteration (more than 30 disc areas) posterior to the shunt vessels within vascularised retina.
CONCLUSIONS: Features of severe capillary bed loss in the vascularised retina were seen in our cases. Oxygen could be a precipitating factor in causing this retinopathy of prematurity in large babies.

Entities:  

Mesh:

Year:  2012        PMID: 22611114     DOI: 10.1136/fetalneonatal-2011-301121

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  37 in total

Review 1.  Retinopathy of prematurity.

Authors:  Ann Hellström; Lois E H Smith; Olaf Dammann
Journal:  Lancet       Date:  2013-06-17       Impact factor: 79.321

2.  VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesis.

Authors:  Zhihong Yang; Haibo Wang; Yanchao Jiang; M Elizabeth Hartnett
Journal:  Am J Pathol       Date:  2014-03-12       Impact factor: 4.307

Review 3.  Advances in understanding and management of retinopathy of prematurity.

Authors:  Mary Elizabeth Hartnett
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

Review 4.  Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity.

Authors:  M Elizabeth Hartnett
Journal:  Clin Perinatol       Date:  2014-09-23       Impact factor: 3.430

Review 5.  Pathophysiology and mechanisms of severe retinopathy of prematurity.

Authors:  M Elizabeth Hartnett
Journal:  Ophthalmology       Date:  2014-10-14       Impact factor: 12.079

6.  Larger and near-term baby retinopathy: a rare case series.

Authors:  T R Padhi; S Rath; S Jalali; L Pradhan; S Kesarwani; M Nayak; B Mishra; K G Panda; S Suttar
Journal:  Eye (Lond)       Date:  2014-10-31       Impact factor: 3.775

Review 7.  The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment.

Authors:  Lois E Smith; Anna-Lena Hard; Ann Hellström
Journal:  Clin Perinatol       Date:  2013-06       Impact factor: 3.430

8.  Aggressive Posterior Retinopathy of Prematurity: Clinical and Quantitative Imaging Features in a Large North American Cohort.

Authors:  Kellyn N Bellsmith; James Brown; Sang Jin Kim; Isaac H Goldstein; Aaron Coyner; Susan Ostmo; Kishan Gupta; R V Paul Chan; Jayashree Kalpathy-Cramer; Michael F Chiang; J Peter Campbell
Journal:  Ophthalmology       Date:  2020-02-07       Impact factor: 12.079

Review 9.  An Update on Retinopathy of Prematurity (ROP).

Authors:  Mangat Ram Dogra; Deeksha Katoch; Mohit Dogra
Journal:  Indian J Pediatr       Date:  2017-07-04       Impact factor: 1.967

10.  Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF/VEGFR2 pathway.

Authors:  Hua Liu; Wenbo Zhang; Zhimin Xu; Robert W Caldwell; Ruth B Caldwell; Steven E Brooks
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.